Medtronic, Inc. Wavers on Report of Infuse Complications

NEW YORK -Shares of Medtronic Inc. slipped Thursday as investors digested mixed news about its implantable heart devices and the company’s Infuse bone graft.

MORE ON THIS TOPIC